DaVita Inc DVA

NYS: DVA | ISIN: US23918K1088   7/06/2023
100,56 USD (+1,29%)
(+1,29%)   7/06/2023

10 mei 2023 · DaVita Recognizes Nephrology Nurses with DAISY Award · Persbericht

8 mei 2023 · DaVita Inc. 1st Quarter 2023 Results · Persbericht

4 mei 2023 · DaVita Celebrates Corporate Citizenship Achievements, Releases its 2022 Community Care Report · Persbericht

2 mei 2023 · DaVita Inc. to Participate in the BofA Securities Healthcare Conference 2023 · Persbericht

18 april 2023 · DaVita Inc. Schedules 1st Quarter 2023 Investor Conference Call · Persbericht

4 april 2023 · Lex Ferenda Litigation Funding Expands To Denver; Announces Addition Of Prominent Litigator And In-House Attorney Andrew Kelley · Persbericht

1 april 2023 · Medtronic, DaVita launch Mozarc Medical, aimed at introducing new solutions for patients with kidney failure · Persbericht

13 maart 2023 · DaVita Inc. to Participate in the Barclays 2023 Global Healthcare Conference · Persbericht

22 februari 2023 · DaVita Inc. 4th Quarter 2022 Results · Persbericht

1 februari 2023 · DaVita Inc. Schedules 4th Quarter 2022 Investor Conference Call · Persbericht

31 januari 2023 · DaVita Emphasized Holistic Care for Kidney Patients and Teammates in 2022 · Persbericht

20 december 2022 · DaVita's Move It with Purpose Event Raises Funds for Bridge of Life · Persbericht

3 november 2022 · DaVita Clinical Research Showcases Chronic Kidney Disease and Rare Disease Network, Presents New Research Findings at Kidney Week 2022 · Persbericht

28 oktober 2022 · DaVita Inc. 3rd Quarter 2022 Results · Persbericht

14 oktober 2022 · DaVita Inc. Schedules 3rd Quarter 2022 Investor Conference Call · Persbericht

10 oktober 2022 · The DaVita Giving Foundation Provides $1.4 Million Grant Toward Addressing Food Insecurity · Persbericht

13 september 2022 · DaVita Announces Adam H. Schechter to Join its Board of Directors · Persbericht

1 augustus 2022 · DaVita Inc. 2nd Quarter 2022 Results · Persbericht

25 juli 2022 · American Diabetes Association Focuses on Prevention of Kidney Disease through Collaboration with DaVita · Persbericht

18 juli 2022 · DaVita Inc. Schedules 2nd Quarter 2022 Investor Conference Call · Persbericht

Mijn selecties